| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/13/2003 | CA2455100A1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454238A1 Method of detecting protease activity in a cell |
| 02/13/2003 | CA2454088A1 Method for selecting antibody expressing cells |
| 02/13/2003 | CA2453937A1 Antigenic polypeptides |
| 02/13/2003 | CA2453522A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/13/2003 | CA2453372A1 Methylation resistant vectors |
| 02/13/2003 | CA2451142A1 Carotenoid ketolase gene |
| 02/12/2003 | EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/12/2003 | EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283259A1 Chondroitin polymerase and DNA encoding the same |
| 02/12/2003 | EP1283257A2 Cell having modified cell membrane |
| 02/12/2003 | EP1283057A1 Cell proliferation inhibitors |
| 02/12/2003 | EP1283053A1 Inhibitors of HER3 activity |
| 02/12/2003 | EP1282717A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence |
| 02/12/2003 | EP1282714A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
| 02/12/2003 | EP1282713A2 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
| 02/12/2003 | EP1282712A2 Synthetic gagpol genes and their uses |
| 02/12/2003 | EP1282708A1 A method for generating hypermutable plants |
| 02/12/2003 | EP1282706A2 Natrium-calcium exchanger protein |
| 02/12/2003 | EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 02/12/2003 | EP1282703A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
| 02/12/2003 | EP1282699A2 Splice-region antisense composition and method |
| 02/12/2003 | EP1282697A1 A construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences |
| 02/12/2003 | EP1282696A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 02/12/2003 | EP1282693A1 Human coagulation factor vii variants |
| 02/12/2003 | EP1282691A1 Method for preventing allograft rejection |
| 02/12/2003 | EP1282690A1 Isolation of precursor cells and their use for tissue repair |
| 02/12/2003 | EP1282685A2 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 02/12/2003 | EP1282684A2 Chondroitin synthase gene and methods of making and using same |
| 02/12/2003 | EP1282646A2 Human monoclonal antibodies to dendritic cells |
| 02/12/2003 | EP1282641A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
| 02/12/2003 | EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 02/12/2003 | EP1282449A2 Treatment of human papillomavirus (hpv)-infected cells |
| 02/12/2003 | EP1282434A1 Method for cell adhesion and wound healing |
| 02/12/2003 | EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 02/12/2003 | EP0954563A4 Animal cell culture media comprising plant-derived nutrients |
| 02/12/2003 | EP0889690B1 Antibiotic cocktail and method of use |
| 02/12/2003 | EP0694068B1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396805A Transgenic coat producing milk containing human granulocyte-colony stimulating factor |
| 02/12/2003 | CN1101467C Ephedra cell ZHJ-25 CGMCCNO.0359 and induction method |
| 02/11/2003 | WO2002014871A1 Method of detecting or assaying hbv |
| 02/11/2003 | US6518487 Isolated nucleic acid; increases transformation efficiency; use to control cell division and cell cycle regulation |
| 02/11/2003 | US6518485 Particle-mediated conifer transformation |
| 02/11/2003 | US6518413 Isolated nucleic acid encoding the polypeptide which, on expression in a host cell, produces the polypeptide; use in treatment of muscular dystrophy |
| 02/11/2003 | US6518412 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 02/11/2003 | US6518403 Antibodies that bind an adipocyte-specific protein homolog |
| 02/11/2003 | US6518256 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/11/2003 | US6518255 Administering, via multiple applications to target tissue, a dose of an adenoviral vector comprising a DNA encoding an angiogenic peptide which is an endothelial growth factor and a carrier to increase level of perfusion of blood to target |
| 02/11/2003 | US6518236 FGF homologs |
| 02/11/2003 | US6518066 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
| 02/11/2003 | US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor |
| 02/11/2003 | US6518061 Interleukin-13 (IL-13); Delivery of a modified Pseudomonas exotoxin (effector molecule), attached to an interleukin, to tumor cells bearing interleukin receptors; antitumor agent |
| 02/11/2003 | US6518052 Human homologue of yeast helicase and uses thereof |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells |
| 02/11/2003 | US6518041 An isolated non-protein-encoding nucleic acid sequence functioning as a hormone response element which binds an androgen- or a progesterone- regulated receptor, comprising: a DNA sequence of the formula (SEQ ID NO:6) (N)x TCTCATTCTGTTCC, |
| 02/11/2003 | US6518035 methods of screening for a molecule that inhibits the expression or activity of a protein encoded by a target gene which affects the fitness of a cell. The methods are based on a co-culture assay, and entail culturing together two cell |
| 02/11/2003 | US6518019 Enzymatic polypeptide for use as tools in the generation and amplification of preferential nucleotide sequences |
| 02/11/2003 | US6518010 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 02/11/2003 | US6517835 Growth differentiation factor-11 |
| 02/11/2003 | US6517833 Vision defects |
| 02/11/2003 | US6517830 In vivo gene delivery of nucleic acid sequences encoding the factor VIII protein to the liver endothelial sinusoidal cells; use in the gene therapy treatment of hemophilia A |
| 02/11/2003 | CA2231409C Antibodies specific for native prpsc |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2170509C Dna encoding prostaglandin receptor ep2 |
| 02/11/2003 | CA2142181C Androgen regulation with dna sequences of rat probasin gene |
| 02/11/2003 | CA2133843C Melanocyte stimulating hormone receptor and uses |
| 02/11/2003 | CA1341419C Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid ti plasmid vectors useful for this process |
| 02/10/2003 | CA2396536A1 Human stem cells originated from human amniotic mesenchymal cell layer |
| 02/08/2003 | CA2396616A1 Modified cdna for high expression levels of factor viii and its derivatives |
| 02/06/2003 | WO2003010540A1 Method of identifying nmda-related agent |
| 02/06/2003 | WO2003010539A1 Method and means for detecting alcohol consumption |
| 02/06/2003 | WO2003010333A2 Methods for gene disruption and uses thereof |
| 02/06/2003 | WO2003010321A1 Recombinant vectors derived from adeno-associated virus expressing tam67 for gene therapy |
| 02/06/2003 | WO2003010315A1 Abca7 splicing variant |
| 02/06/2003 | WO2003010314A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 02/06/2003 | WO2003010312A2 Nucleic acid sequences encoding enantioselective amidases |
| 02/06/2003 | WO2003010305A1 Immortilized stem cells |
| 02/06/2003 | WO2003010304A2 Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture |
| 02/06/2003 | WO2003010303A1 Methods of inducing differentiation of stem cells |
| 02/06/2003 | WO2003010302A1 Cultured cell construct containing spheroids of cultured animal cells and utilization thereof |
| 02/06/2003 | WO2003010301A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| 02/06/2003 | WO2003010300A2 Uses of biomaterial substrates |
| 02/06/2003 | WO2003010294A2 Genes involved in the biosynthesis of isopentenyl diphosphate in hevea brasiliensis latex |
| 02/06/2003 | WO2003010292A2 Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors |
| 02/06/2003 | WO2003010290A2 Novel class ii cytokine receptors and uses thereof |
| 02/06/2003 | WO2003010282A2 Interleukin-1 beta antibodies |
| 02/06/2003 | WO2003010243A2 Multipotent stem cells from peripheral tissues and uses thereof |
| 02/06/2003 | WO2003010202A1 Concatameric immunoadhesion |
| 02/06/2003 | WO2003010201A2 Blood group antigen fusion polypeptides and methods of use thereof |
| 02/06/2003 | WO2003010200A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus |
| 02/06/2003 | WO2003010196A2 Variants and exons of the glyt1 transporter |
| 02/06/2003 | WO2003009889A1 Method for enriching cells |
| 02/06/2003 | WO2003009857A1 Treatment of muscular dystrophy with cord blood cells |
| 02/06/2003 | WO2003009815A2 Compositions and methods for modulating blood-brain barrier transport |
| 02/06/2003 | WO2003009814A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |